• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>Biotech HOLDRs

Biotech HOLDRs

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Publicis Groupe 2014 First-half Results - Interview with Maurice Lévy

    Publicis Groupe 2014 First-half Results - Interview with Maurice Lévy

  2. BBH Stays Unhedged With New Global Fund

    BBH Global Core Select manager Tim Hartch avoids currency hedging so he can eliminate complexities in managing the portfolio and maintain a focus on stable underlying businesses.

  3. Hartch: BBH Fund Closure Protecting Against Future Flows

    BBH Core Select comanager Tim Hartch and his team recently closed the fund to better manage the strategy through organic growth than though the anticipated inflows.

  4. BBH's Core Focus on Google

    By homing in on Google's core revenue-generating operations, BBH manager Tim Hartch sees a value proposition in the online firm, with Google's other investments being gravy.

  5. Timothy Hartch and Michael Keller, BBH Core Select

    Skittish about stocks? The managers of BBH Core Select have carefully constructed a 30-name portfolio that has been more stable than the market.

  6. BBH Rolls Out Its First Mutual Fund Since 2002

    Brown Brothers Harriman launches a concentrated large-blend fund investing in U.S. and foreign stocks; Vanguard reopens its Capital Opportunity fund to individual investors; Franklin Templeton rolls out an emerging-markets bond fund; USAA seeks permission to create actively managed ETFs; and ...

1234
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.